UK Policy
CQC Concerns Add to Scrutiny of UK Private Medical Cannabis Clinics
The Care Quality Commission has raised concerns about the standard of care in private medical cannabis clinics. Here's what it means for patients.
INDEPENDENT · UK · PATIENT-FIRST
Medical cannabis in the UK,
covered properly.
Daily briefings, patient tools and guides for the system nobody explains.
PATIENT TOOLS
Compare clinics Every major UK clinic — fees, models and onboarding speed, side by side. Open tool → Eligibility checker Could you qualify? How the UK system actually works, in two minutes. Open tool → Strain explorer Cannabinoid ranges, terpenes and UK availability — built for patients. Open tool →
Conference
Cannabis Europa 2026: The Continent Accelerates as the UK Stands Still
At Cannabis Europa London 2026, held in May, delegates confronted a stark divide: the EU races toward regulatory harmonisation and adult-use reform, while the UK remains mired in a stalled medical programme. Investment is flowing east, and the conversation has shifted from ‘if’ to ‘when’ for adult-use in countries like the Czech Republic and the Netherlands.
Read the briefingLatest Briefings
View All →
UK Policy
The UK Medical Cannabis Market: Growth, Challenges and the Road Ahead
The UK medical cannabis market is expanding rapidly, but significant barriers remain for patients. A comprehensive look at where things stand in May 2026.
Patient Stories
Patient Experiences: Navigating Stigma in the UK Healthcare System
Patients report that stigma around cannabis as medicine remains one of the biggest challenges — often within the healthcare system itself.
United Kingdom
All UK →UK Policy
CQC Concerns Add to Scrutiny of UK Private Medical Cannabis Clinics
The Care Quality Commission has raised concerns about the standard of care in private medical cannabis clinics. Here's what it means for patients.
UK Policy
The UK Medical Cannabis Market: Growth, Challenges and the Road Ahead
The UK medical cannabis market is expanding rapidly, but significant barriers remain for patients. A comprehensive look at where things stand in May 2026.
Patient Stories
Patient Experiences: Navigating Stigma in the UK Healthcare System
Patients report that stigma around cannabis as medicine remains one of the biggest challenges — often within the healthcare system itself.
World
Europe, USA & Global →Conference
Cannabis Europa 2026: The Continent Accelerates as the UK Stands Still
At Cannabis Europa London 2026, held in May, delegates confronted a stark divide: the EU races toward regulatory harmonisation and adult-use reform, while the UK remains mired in a stalled medical programme. Investment is flowing east, and the conversation has shifted from ‘if’ to ‘when’ for adult-use in countries like the Czech Republic and the Netherlands.
USA
Green Gold Rush: US Medical Cannabis Market on Track to Surpass $45 Billion by 2027, Q1 2026 Report Reveals
Q1 2026 data projects US medical cannabis market to exceed $45 billion by 2027, with record sales but price compression squeezing multi-state operators in mature western states.
Global
Global Cannabis Reform Roundup: Policy Changes Across the World
From Germany to Brazil, the global cannabis reform landscape is shifting rapidly. A roundup of the major policy developments you need to know.